Accutest Global is a global CRO (Contract Research Organization) that offers comprehensive drug development and testing services. With a 21-year consistent global track record, Accutest Global is a trusted partner for generic and innovator companies. What sets Accutest Global apart is its commitment to being truly independent, with no stake or partnership with any pharmaceutical company, ensuring the highest quality and unbiased results.

Accutest Global provides a wide range of services including phase I BA/BE studies, clinical trials from proof of concept to global submissions, services for biosimilars, and specialized solutions in pharmacokinetic and statistical analysis. They have a team of experienced professionals who are experts in executing complex studies and handling analytical challenges. Accutest Global adheres to international quality standards such as US FDA, WHO, EMA, ANVISA, DCGI, MCC, and many more.

They offer competitive pricing and global best practices with delivery capabilities focused on key emerging markets. With state-of-the-art infrastructure and facilities, including clinical units and bioanalytical labs, Accutest Global ensures quick turnaround time and high-quality services. Accutest Global's team of clinical investigators, analytical investigators, quality assurance, regulatory affairs, biostatisticians, and project management professionals ensure efficient and regulatory compliant operations for phase II to IV clinical development services.

They provide clinical trial feasibility and patient access planning, project management and planning, clinical monitoring, medical monitoring, clinical data management and biostatistics, medical writing and safety, and regulatory affairs services. Overall, Accutest Global offers everything in one place for comprehensive and reliable drug development and testing services